Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages - PubMed (original) (raw)
Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages
Jaehyup Kim et al. Exp Hematol. 2009 Dec.
Abstract
Objective: Mesenchymal stem cells (MSCs) are capable of modulating the immune system through interaction with a wide range of immune cells. This study investigates the hypothesis that interaction of MSCs with macrophages could play a significant role in their antiinflammatory/immune modulatory effects.
Materials and methods: MSCs were derived from bone marrow and monocytes were isolated from peripheral blood of healthy donors. We cultured human monocytes for 7 days without any added cytokines to generate macrophages, and then cocultured them for 3 more days with culture-expanded MSCs. We used cell surface antigen expression and intracellular cytokine expression patterns to study the immunophenotype of macrophages at the end of this coculture period, and phagocytic assays to investigate their functional activity in vitro.
Results: Macrophages cocultured with MSCs consistently showed high-level expression of CD206, a marker of alternatively activated macrophages. Furthermore, these macrophages expressed high levels of interleukin (IL)-10 and low levels of IL-12, as determined by intracellular staining, typical of alternatively activated macrophages. However, macrophages cocultured with MSCs also expressed high levels of IL-6 and low levels of tumor necrosis factor-alpha (TNF-alpha) compared to controls. Functionally, macrophages cocultured with MSCs showed a higher level of phagocytic activity.
Conclusions: We describe a novel type of human macrophage generated in vitro after coculture with MSCs that assumes an immunophenotype defined as IL-10-high, IL-12-low, IL-6-high, and TNF-alpha-low secreting cells. These MSC-educated macrophages may be a unique and novel type of alternatively activated macrophage with a potentially significant role in tissue repair.
Figures
Figure-1
Comparison of expression of CD206 cell surface marker on macrophages co-cultured in direct contact to MSCs (MSC) or within a transwell system (Transwell), and without any MSCs (Control). Results are shown comparing mean fluorescence intensity of CD206 expression.
Figure-2
Gating strategy to separate macrophage from MSC and comparison of expression of IL-10 in MSC co-cultured macrophage versus control macrophage. A) Gating of MSC co-cultured macrophages using CD14 APC and CD90 PerCP-Cy5.5; B) Isotype control to show specificity of IL-10 staining of MSC co-cultured macrophage; C) Expression of IL10 in MSC co-cultured macrophages; D) Expression of IL-10 in control macrophages.
Figure-3
Intracellular cytokine staining of MSC co-cultured and control macrophages. A) MSC co-cultured macrophages stained with anti-IL-12 PE; B) Control macrophage stained with anti-IL12 PE; C) MSC co-cultured macrophage stained with anti-IL6 PE; D) Control macrophage stained with anti-IL6 PE; E) MSC co-cultured macrophage stained with anti-TNF-α PE; F) Control macrophage stained with anti-TNF-α PE.
Figure-4
Fold changes of percentages of MSC co-cultured macrophages versus control macrophage positively stained for the intracellular target cytokine.
Figure-5
Phagocytic assay: A) Gating strategy for MSC co-cultured macrophages looking at CD14+ CD90− cells; B) Gating of control macrophages; C) MSC co-cultured macrophage in gray and control macrophage in white, Incubated at 4° C for 1 hour; D) MSC co-cultured macrophages in gray and control macrophage in white incubated at 37° C for 1 hour.
Similar articles
- The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages.
Hanson SE, King SN, Kim J, Chen X, Thibeault SL, Hematti P. Hanson SE, et al. Tissue Eng Part A. 2011 Oct;17(19-20):2463-71. doi: 10.1089/ten.TEA.2010.0716. Epub 2011 Jun 24. Tissue Eng Part A. 2011. PMID: 21554192 Free PMC article. - Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
Philipp D, Suhr L, Wahlers T, Choi YH, Paunel-Görgülü A. Philipp D, et al. Stem Cell Res Ther. 2018 Oct 25;9(1):286. doi: 10.1186/s13287-018-1039-2. Stem Cell Res Ther. 2018. PMID: 30359316 Free PMC article. - Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis.
Lin T, Pajarinen J, Nabeshima A, Lu L, Nathan K, Jämsen E, Yao Z, Goodman SB. Lin T, et al. Stem Cell Res Ther. 2017 Dec 6;8(1):277. doi: 10.1186/s13287-017-0730-z. Stem Cell Res Ther. 2017. PMID: 29212557 Free PMC article. - Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages.
Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, Abomaray FM, Fatani AS, Chamley LW, Knawy BA. Abumaree MH, et al. Stem Cell Rev Rep. 2013 Oct;9(5):620-41. doi: 10.1007/s12015-013-9455-2. Stem Cell Rev Rep. 2013. PMID: 23812784 - Mesenchymal stem cells promote CD206 expression and phagocytic activity of macrophages through IL-6 in systemic lupus erythematosus.
Deng W, Chen W, Zhang Z, Huang S, Kong W, Sun Y, Tang X, Yao G, Feng X, Chen W, Sun L. Deng W, et al. Clin Immunol. 2015 Dec;161(2):209-16. doi: 10.1016/j.clim.2015.07.011. Epub 2015 Jul 22. Clin Immunol. 2015. PMID: 26209923
Cited by
- Human Bone Marrow Mesenchymal Stem Cells Promote the M2 Phenotype in Macrophages Derived from STEMI Patients.
Cortés-Morales VA, Vázquez-González WG, Montesinos JJ, Moreno-Ruíz L, Salgado-Pastor S, Salinas-Arreola PM, Díaz-Duarte K, Chávez-Rueda AK, Chávez-Sánchez L. Cortés-Morales VA, et al. Int J Mol Sci. 2023 Nov 13;24(22):16257. doi: 10.3390/ijms242216257. Int J Mol Sci. 2023. PMID: 38003447 Free PMC article. - Microglia differentiation using a culture system for the expansion of mice non-adherent bone marrow stem cells.
Hinze A, Stolzing A. Hinze A, et al. J Inflamm (Lond). 2012 Apr 2;9(1):12. doi: 10.1186/1476-9255-9-12. J Inflamm (Lond). 2012. PMID: 22471998 Free PMC article. - Mesenchymal Stem Cells Attenuate Asthmatic Inflammation and Airway Remodeling by Modulating Macrophages/Monocytes in the IL-13-Overexpressing Mouse Model.
Mo Y, Kim Y, Bang JY, Jung J, Lee CG, Elias JA, Kang HR. Mo Y, et al. Immune Netw. 2022 Sep 27;22(5):e40. doi: 10.4110/in.2022.22.e40. eCollection 2022 Oct. Immune Netw. 2022. PMID: 36381962 Free PMC article. - Macrophages in multiple myeloma: emerging concepts and therapeutic implications.
Asimakopoulos F, Kim J, Denu RA, Hope C, Jensen JL, Ollar SJ, Hebron E, Flanagan C, Callander N, Hematti P. Asimakopoulos F, et al. Leuk Lymphoma. 2013 Oct;54(10):2112-21. doi: 10.3109/10428194.2013.778409. Epub 2013 Apr 11. Leuk Lymphoma. 2013. PMID: 23432691 Free PMC article. Review. - Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice.
Siniscalco D, Giordano C, Galderisi U, Luongo L, de Novellis V, Rossi F, Maione S. Siniscalco D, et al. Front Integr Neurosci. 2011 Dec 1;5:79. doi: 10.3389/fnint.2011.00079. eCollection 2011. Front Integr Neurosci. 2011. PMID: 22164136 Free PMC article.
References
- Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow.Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230–247. - PubMed
- Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641–650. - PubMed
- Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147. - PubMed
- Wagner W, Wein F, Seckinger A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Experimental hematology. 2005;33:1402–1416. - PubMed
- Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell stem cell. 2008;3:301–313. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K08 HL081076/HL/NHLBI NIH HHS/United States
- K08 HL081076-03/HL/NHLBI NIH HHS/United States
- HL081076/HL/NHLBI NIH HHS/United States
- K08 HL081076-02/HL/NHLBI NIH HHS/United States
- K08 HL081076-01A2/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources